logo
Fitter & Stronger: Midcaps outperform smallcaps in long term

Fitter & Stronger: Midcaps outperform smallcaps in long term

Time of India24-07-2025
"They are no longer small or unproven; many have solid balance sheets, professional management, and institutional interest."
Mutual funds focusing on midcap stocks have shown strong returns for SIP investors over time. Nifty Midcap 150 TRI has surpassed Nifty Smallcap 250 TRI in 10 and 15-year returns. Midcaps offer better risk-adjusted returns and stronger fundamentals. Recent MF inflows have significantly impacted midcap valuations.
Tired of too many ads?
Remove Ads
Tired of too many ads?
Remove Ads
Mumbai: Mutual funds that bet on midcap stocks have worked well for investors who have used systematic investment plans (SIPs) over longer periods, outperforming their smallcap counterparts.A study by Equirus Credence Family Office shows that the Nifty Midcap 150 Total Returns Index (TRI) delivered an average return of 17.3%, vs 15.1% for Nifty Smallcap 250 TRI, based on 10-year rolling returns. Over 15 years, the midcap index returned 16.9% versus 14.1% for the smallcap index."Midcap stocks have outperformed smallcaps over long term offering better risk-adjusted returns , stronger business fundamentals, and higher survivability," says Chanchal Agarwal, CIO, Equirus Credence Family Office.Mutual funds categorise companies ranked 101-250 by market capitalisation as midcaps, while those ranked 251 and below fall under the category of smallcaps.This makes the midcap universe a narrower space compared to small caps, which comprise a much larger and more fragmented set of companies. The recent flood of MF inflows, through SIPs, has had a more concentrated and pronounced impact on midcap stocks, driving valuations and supporting performance.Even over shorter durations of three and five years, the midcap index returned 13.9% and 17.4%, respectively, as against 11.9% and 15.11% for small caps."The best smallcap companies go on to become midcap companies and hence it is logical that over the longer term they offer better returns," says Trideep Bhattacharya, CIO, Edelweiss Mutual Fund.Midcaps also tend to experience lower drawdowns compared to smallcap funds. The minimum return over a five- and ten-year period for a rolling monthly SIP in Nifty Midcap 150 TRI was -8.2% and 6%, respectively. In comparison, the Nifty Smallcap 250 TRI posted minimum returns of -21.2% and 0.2%. The outperformances have resulted in midcaps trading at a premium to blue-chips. The Nifty Midcap 150 is at a PE ratio of 35.21 times as against 22.29 of Nifty. The Nifty Smallcap 250's PE ratio is 33.82 times.Notwithstanding rich valuations, Equirus Credence expects midcaps to continue doing well. "Midcap companies are in a strong position," said Agarwal. "They are no longer small or unproven; many have solid balance sheets, professional management, and institutional interest."
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

No Iron Don to protect D-Street, indices slump 1% under US fire
No Iron Don to protect D-Street, indices slump 1% under US fire

Economic Times

time2 days ago

  • Economic Times

No Iron Don to protect D-Street, indices slump 1% under US fire

India's equity indices ended almost 1% lower on Friday, marking their fifth straight week of losses-the longest losing streak in two years-as concerns over the fallout of US tariffs on Indian exports weighed on sentiment. ADVERTISEMENT The NSE Nifty fell 0.8% or 203 points to finish at 24,565.35. The BSE Sensex moved 0.7% or 585.67 points lower at 80,599.91. Both indices declined 1.1% in the past week. "The structural long-term trend is dictated by the earnings, which are around expectations; however, the challenge is the lack of enough clarity on the tariff front, and this uncertainty is expected to linger," said Pankaj Pandey, head of retail research at ICICI Direct. "From that perspective, the market is lacking a near-term trigger for a decisive move." The recent losing run, initially triggered by fatigue after a strong rebound, has been exacerbated by Donald Trump's announcement that the US will impose 25% tariffs on Indian exports, along with an additional non-tariff penalty for buying crude oil and military equipment from said a pullback was due after Nifty's surge from 22,000 levels to almost 25,700 levels in the last couple of months. ADVERTISEMENT "The five consecutive weeks of losses in Nifty were marked by foreign selling with the overseas investors remaining 90% short on index futures-a multi-month low that added selling pressure amid tariff imposition concerns," said Nilesh Jain, head of derivatives and technical research at Centrum are watching whether the Nifty is able to hold above a key support of 24,000. ADVERTISEMENT "A further dip towards the 200-day moving average of 24,000 levels could be a short-term bottom, and investors can accumulate quality stocks," said Jain. "A sharp and sustainable rebound is expected around 24,000 levels, but it may take some more time to materialise." The Nifty Midcap 150 and the Smallcap 250 indices declined 1.3% and 1.6%, respectively, on Friday. Out of the 4,169 shares traded on the BSE, 1,297 advanced, while 2,718 declined. In the past week, the mid-cap index shed 1.9% while the small-cap index tumbled 3%. ADVERTISEMENT Pharma stocks were among the top losers on reports that Trump has asked 17 of the world's biggest pharmaceutical majors to lower prices of existing drugs. Sun Pharmaceutical Industries tumbled 4.5% on Friday, emerging as the biggest loser on the index, after the first-quarter net profit fell 20%. The Nifty Pharma index dropped 3.3%Foreign portfolio investors (FPIs) sold shares worth a net of ₹3,366.4 crore on Friday. Their domestic counterparts bought shares worth ₹3,186.9 crore. In July, overseas investors dumped shares worth 38,214.5 crore- the highest selling since February this home, the Volatility Index or VIX-the market's fear gauge-gained 3.7% to almost 12 on Friday, indicating traders expect higher risks in the near term. ADVERTISEMENT Elsewhere in Asia, South Korea tumbled almost 4%, while Hong Kong and Japan fell 1.1% and 0.7%, respectively. China and Taiwan declined around 0.5% each.

No Iron Don to protect D-Street, indices slump 1% under US fire
No Iron Don to protect D-Street, indices slump 1% under US fire

Time of India

time2 days ago

  • Time of India

No Iron Don to protect D-Street, indices slump 1% under US fire

India's equity indices ended almost 1% lower on Friday, marking their fifth straight week of losses-the longest losing streak in two years-as concerns over the fallout of US tariffs on Indian exports weighed on sentiment. The NSE Nifty fell 0.8% or 203 points to finish at 24,565.35. The BSE Sensex moved 0.7% or 585.67 points lower at 80,599.91. Both indices declined 1.1% in the past week. Explore courses from Top Institutes in Please select course: Select a Course Category MBA others healthcare Design Thinking MCA Management Operations Management CXO Project Management Healthcare Technology Product Management Data Science Digital Marketing Leadership Finance Data Analytics Data Science Public Policy Artificial Intelligence PGDM Others Degree Cybersecurity Skills you'll gain: Financial Management Team Leadership & Collaboration Financial Reporting & Analysis Advocacy Strategies for Leadership Duration: 18 Months UMass Global Master of Business Administration (MBA) Starts on May 13, 2024 Get Details Skills you'll gain: Analytical Skills Financial Literacy Leadership and Management Skills Strategic Thinking Duration: 24 Months Vellore Institute of Technology VIT Online MBA Starts on Aug 14, 2024 Get Details by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Roof Repair or Replacement? Compare the Cost Now Roofing Services | Search Ads Learn More Undo "The structural long-term trend is dictated by the earnings, which are around expectations; however, the challenge is the lack of enough clarity on the tariff front, and this uncertainty is expected to linger," said Pankaj Pandey, head of retail research at ICICI Direct. "From that perspective, the market is lacking a near-term trigger for a decisive move." The recent losing run, initially triggered by fatigue after a strong rebound, has been exacerbated by Donald Trump's announcement that the US will impose 25% tariffs on Indian exports, along with an additional non-tariff penalty for buying crude oil and military equipment from Russia. Analysts said a pullback was due after Nifty's surge from 22,000 levels to almost 25,700 levels in the last couple of months. Live Events "The five consecutive weeks of losses in Nifty were marked by foreign selling with the overseas investors remaining 90% short on index futures-a multi-month low that added selling pressure amid tariff imposition concerns," said Nilesh Jain, head of derivatives and technical research at Centrum Broking. Traders are watching whether the Nifty is able to hold above a key support of 24,000. "A further dip towards the 200-day moving average of 24,000 levels could be a short-term bottom, and investors can accumulate quality stocks," said Jain. "A sharp and sustainable rebound is expected around 24,000 levels, but it may take some more time to materialise." The Nifty Midcap 150 and the Smallcap 250 indices declined 1.3% and 1.6%, respectively, on Friday. Out of the 4,169 shares traded on the BSE, 1,297 advanced, while 2,718 declined. In the past week, the mid-cap index shed 1.9% while the small-cap index tumbled 3%. Pharma stocks were among the top losers on reports that Trump has asked 17 of the world's biggest pharmaceutical majors to lower prices of existing drugs. Sun Pharmaceutical Industries tumbled 4.5% on Friday, emerging as the biggest loser on the index, after the first-quarter net profit fell 20%. The Nifty Pharma index dropped 3.3% Foreign portfolio investors (FPIs) sold shares worth a net of ₹3,366.4 crore on Friday. Their domestic counterparts bought shares worth ₹3,186.9 crore. In July, overseas investors dumped shares worth 38,214.5 crore- the highest selling since February this year. At home, the Volatility Index or VIX-the market's fear gauge-gained 3.7% to almost 12 on Friday, indicating traders expect higher risks in the near term. Elsewhere in Asia, South Korea tumbled almost 4%, while Hong Kong and Japan fell 1.1% and 0.7%, respectively. China and Taiwan declined around 0.5% each.

Jio Financial Services shares in focus after board approves Rs 15,825 crore fundraise via warrants
Jio Financial Services shares in focus after board approves Rs 15,825 crore fundraise via warrants

Economic Times

time4 days ago

  • Economic Times

Jio Financial Services shares in focus after board approves Rs 15,825 crore fundraise via warrants

Shares of Jio Financial Services will be in focus on Thursday after the company's board approved a proposal to raise up to Rs 15,825 crore through the preferential issue of 50 crore warrants. ADVERTISEMENT The warrants will be issued for cash at Rs 316.50 each, including a face value of Rs 10 and a premium of Rs 306.50. Each warrant is convertible into one fully paid-up equity share and will be allotted on a private placement basis to promoter group entities, subject to shareholder and regulatory approvals. The conversion can be done in one or more tranches within 18 months from the allotment date. Warrants not converted in time will lapse, and the amount paid will be forfeited. Jio Financial Services reported a net profit of Rs 325 crore for Q1FY26, up 4% from Rs 312.63 crore in the year-ago period. Revenue rose 46.6% year-on-year to Rs 612.46 crore from Rs 417.82 Jio BlackRock — the firm's 50:50 joint venture with BlackRock — has received SEBI approval to launch four passive funds. These include index funds tracking the Nifty Midcap 150, Nifty Next 50, Nifty Smallcap 250, and the Nifty 8–13 Year G-Sec Index. ADVERTISEMENT According to Trendlyne, the average target price for Jio Financial Services is Rs 301, indicating a potential downside of about 6%. Of the two analysts tracking the stock, the consensus recommendation is 'Hold'.On the technical front, the stock is showing a neutral trend. The Relative Strength Index (RSI) stands at 56.2, indicating balanced momentum. The MACD is at 4.0—above the centre line but below the signal line. ADVERTISEMENT The stock is trading above all key long-term moving averages (30-day, 50-day, 100-day, 150-day, and 200-day), suggesting strength in the broader uptrend. However, it is currently below short-term averages such as the 20-day SMA. (Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times) ADVERTISEMENT (You can now subscribe to our ETMarkets WhatsApp channel)

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store